Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Thromb Thrombolysis ; 49(2): 199-205, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-31422520

RESUMO

Thrombosis resolution is an important component of treatment for deep vein thrombosis (DVT) and multiple anticoagulants are now available. It is unknown whether rivaroxaban contributes to a higher degree of thrombus resolution compared to conventional anticoagulation with warfarin. Our objective was to compare thrombus resolution for rivaroxaban versus warfarin treated patients with acute lower extremity DVT. Consecutive patients treated for proximal or distal lower extremity DVT with rivaroxaban were identified from the Mayo Thrombophilia Clinic Anticoagulants Registry (November 2015-June 2016) and compared to patients treated with warfarin. Ultrasonography/Doppler images were analyzed by two independent radiologists blinded to anticoagulant and using a standardized assessment algorithm. A total of 111 patients with DVT were studied. Sixty-three rivaroxaban treated patients were compared to 48 warfarin treated patients over a median follow up of 92 and 97 days, respectively. Percentage of patients with total or partial resolution of thrombosis was similar in rivaroxaban and warfarin treated groups (95.2% vs. 91.7%, p = 0.46, respectively); also the proportion of patients with total thrombus resolution was not significantly different (38.1% vs. 29.2%, p = 0.42, respectively). There was no significant difference in the proportion of patients with no thrombus resolution between rivaroxaban and warfarin treated groups either (4.8% vs. 2.1%, p = 0.63). Thrombus propagation with warfarin therapy was observed in 6.3% of patients treated with warfarin and in none of the patients from the rivaroxaban group (p = 0.08). Resolution of acute lower extremity DVT in patients treated with rivaroxaban is similar to those treated with warfarin.


Assuntos
Anticoagulantes/uso terapêutico , Inibidores do Fator Xa/uso terapêutico , Extremidade Inferior/irrigação sanguínea , Rivaroxabana/uso terapêutico , Trombose Venosa/tratamento farmacológico , Varfarina/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Anticoagulantes/farmacologia , Inibidores do Fator Xa/farmacologia , Feminino , Humanos , Extremidade Inferior/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Sistema de Registros , Rivaroxabana/farmacologia , Ultrassonografia Doppler/métodos , Trombose Venosa/diagnóstico por imagem , Varfarina/farmacologia
3.
Nurs N Z ; 22(10): 25, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-30521730

RESUMO

Coping with the recent campylobacter outbreak which devastated Havelock North was a professional and personal challenge for a Hawke's Bay nurse practitioner.


Assuntos
Infecções por Campylobacter/enfermagem , Surtos de Doenças , Água Potável/microbiologia , Gastroenterite/enfermagem , Adaptação Psicológica , Infecções por Campylobacter/epidemiologia , Gastroenterite/epidemiologia , Humanos , Nova Zelândia/epidemiologia , Profissionais de Enfermagem , População Rural
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...